Alvotech Expands Biosimilar Reach With Lotus Partnership
Reykjavik, Iceland, August 21, 2026 Alvotech, a biotechnology company focused on the development and manufacture of biosimilar medicines, has...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Reykjavik, Iceland, August 21, 2026 Alvotech, a biotechnology company focused on the development and manufacture of biosimilar medicines, has...
Rancho Cordova, California, USA, August 21, 2026 SK pharmteco, a global contract development and manufacturing organization (CDMO), has announced...
Charleston, South Carolina, August 12, 2026 Salus Scientific announced the launch of its Clinical Insights Series, a new publication...
Shanghai, China, August 12, 2026 Aurisco Pharmaceutical announced that its manufacturing site in Yangzhou, China, has successfully passed a...
MUMBAI, India, May 28, 2026 Lupin Limited, one of the world’s leading pharmaceutical companies, has announced that it has...
BUBENDORF, Switzerland, May 6, 2026 CARBOGEN AMCIS, a global pharmaceutical process development and active pharmaceutical ingredient (API) manufacturing company,...
NEW YORK, NY, May 1, 2026 SK Capital Partners, LP announced the successful completion of the sale of Noramco...
MENLO PARK, CA — November 20, 2025 — Antheia announced a strategic partnership with TAPI (Teva Active Pharmaceutical Ingredients)...
Norwood, Massachusetts – October 31, 2025 — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), an oncology and obesity-focused biotechnology company,...
TOKYO, Japan – October 31, 2025 — Nxera Pharma Co., Ltd. announced that its subsidiary, Nxera Pharma Japan, has...
